Answers are grounded in this paper and cite their sources.
The meta-analysis strongly supports the prognostic role of BCL2 as assessed by immunohistochemistry in breast cancer and shows that this effect is independent of lymph node status, tumour size and tumour grade as well as a range of other biological variables on multi-variate analysis. Large prospective studies are now needed to establish the clinical utility of BCL2 as an independent prognostic marker.
No takes yet. Share an insight, caveat, or question.
Callagy et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: